Global Over The Counter Drugs Market | Market Research Report

The Global Over The Counter Drugs Market to grow from USD 318,021.67 Million in 2018 to USD 551,280.67 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 8.17%. Some of the major market players include Bayer AG, Johnson & Johnson, Novartis AG, Pfizer Inc., and Sanofi S.A..

360iResearch Logo
Global Over The Counter Drugs Market
Report Code: MRR-7358D27 | Publishing Date: | Number of Pages: 150
Global Over The Counter Drugs Market | Market Research Report

Market Dynamics:

The factors attributing to the growth of the market are reduced burden of the physician, favorable regulatory framework, and cost effective way to treat minor health issues. However, some factors such as presence of substitute drug due to saturating market may hinder the market growth. The Over The Counter Drugs Market is expected to showcase the opportunities such as technological advancement and product innovation and increased accessibility through retail outlets and supermarkets. In the near future market may face the possible challenges in the growth due to pressure to keep the price low. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the Over The Counter Drugs Market.

Market Segmentation & Coverage:

The research report categorizes the Over The Counter Drugs Market to forecast the revenues and analyze the trends in each of the following segments:

On the basis of Product, the Over The Counter Drugs Market is studied across Analgesics, Cough, Cold, and Flu Products, Dermatology Products, Gastrointestinal Products, Ophthalmic Products, Sleeping Aids, Vitamins, Mineral, and Supplements (VMS), and Weight-loss/Dietary Products.

On the basis of Distribution Channel, the Over The Counter Drugs Market is studied across Hospital Parmicies, Online Stores, and Retail Pharmacies.

On the basis of Geography, the Over The Counter Drugs Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.

Company Usability Profiles:

The Over The Counter Drugs Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increasing competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The Over The Counter Drugs Market research report provides the company usability profiles and analyze the overview, strategy, SWOT and scorecard of the following company:

  • Bayer AG
  • Johnson & Johnson
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Alkem Laboratories Limited
  • Boehringer Ingelheim GmbH
  • Cipla, Inc.
  • Glaxosmithkline PLC
  • Glenmark Pharmaceuticals Limited
  • Merck KGaA
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Scope of the Report:

AttributeDetails
Base Year for Estimation2018
Historical Period2016 - 2017
Estimation Period2019 - 2020
Forecast Year2025
Market RepresentationRevenue in USD Million
Report CoverageRevenue Forecast, Company Share, Competitive Landscape, and Industry Trends.
Customization ScopeIf you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization. We offer 20% free customization which is equivalent to 5 analysts working days.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of the Over The Counter Drugs Market. Moreover, the study highlights current market trends and provides forecast. We also have highlighted future trends in the Over The Counter Drugs Market that will impact the demand during the forecast period. Moreover, the competitive analysis of the Over The Counter Drugs Market brings an insight on the company usability profiles of the leading players. Additionally, the analysis highlights business overview, strategy, and SWOT analysis of the key companies in the market.

Reasons to Buy:

The Over The Counter Drugs Market research study reveals hidden insights and dynamic, which in turn helps the players in the ecosystem take better strategic decisions. The firms looking for purchasing the Over The Counter Drugs Market research report could look for following prospects on their way to better understand the market that can aid further decision making and possibly identify the best opportunities to exploit.

  • Evaluate the qualitative and quantitative aspects of the report and analyze the Over The Counter Drugs Market penetration with respect to industries and geographies.
  • Evaluates the key vendors and deeply analyze competitive landscape, revenue pockets, market trends, growth prospects, pain points, drivers, restraints, challenges and opportunities of the Over The Counter Drugs Market .
  • Evaluate the key vendors in the Over The Counter Drugs Market in terms of products satisfaction and business strategy. This helps identify consumer preferences and understand its current position in 360iResearch FPNV Positioning Matrix.
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research & Forecasting
    1. Research Methodology
    2. Forecasting Methodology
  3. Executive Summary
    1. Market Outlook
      1. Need for regulated market space for Over-the-counter drugs
      2. Pharmacies are not able to put patient need ahead of commercial interests
      3. Patient safety access
      4. Why drug makers want a free hand in pricing and advertising of Over the counter drugs
  4. Market Overview
    1. Introduction
    2. Over The Counter Drugs Market, By Geography
    3. Over The Counter Drugs Market, By Product
    4. Over The Counter Drugs Market, By Distribution Channel
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Cost effective way to treat minor health issues
      2. Reduced burden of the physician
      3. Favorable regulatory framework
    3. Restraints
      1. Presence of substitute drug due to saturating market
    4. Opportunities
      1. Increased accessibility through retail outlets and supermarkets
      2. Technological advancement and product innovation
    5. Challenges
      1. Pressure to keep the price low
  6. Industry Trends
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Client Customizations
  7. Over The Counter Drugs Market, By Product
    1. Introduction
    2. Analgesics
    3. Cough, Cold, and Flu Products
    4. Dermatology Products
    5. Gastrointestinal Products
    6. Ophthalmic Products
    7. Sleeping Aids
    8. Vitamins, Mineral, and Supplements (VMS)
    9. Weight-loss/Dietary Products
  8. Over The Counter Drugs Market, By Distribution Channel
    1. Introduction
    2. Hospital Parmicies
    3. Online Stores
    4. Retail Pharmacies
  9. Over The Counter Drugs Market, By Americas
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  10. Over The Counter Drugs Market, By Asia-Pacific
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  11. Over The Counter Drugs Market, By Europe, Middle East & Africa
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  12. Competitive Landscape
    1. FPNV Positioning Matrix
    2. Market Vendor Ranking Analysis
    3. Competitive News Feed Analysis
  13. Company Usability Profiles
    1. Bayer AG
      1. Overview
      2. Strategy
      3. SWOT
    2. Johnson & Johnson
      1. Overview
      2. Strategy
      3. SWOT
    3. Novartis AG
      1. Overview
      2. Strategy
      3. SWOT
    4. Pfizer Inc.
      1. Overview
      2. Strategy
      3. SWOT
    5. Sanofi S.A.
      1. Overview
      2. Strategy
      3. SWOT
    6. Alkem Laboratories Limited
    7. Boehringer Ingelheim GmbH
    8. Cipla, Inc.
    9. Glaxosmithkline PLC
    10. Glenmark Pharmaceuticals Limited
    11. Merck KGaA
    12. Sun Pharmaceutical Industries Ltd.
    13. Teva Pharmaceutical Industries Ltd.
  14. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL OVER THE COUNTER DRUGS MARKET: SEGMENTATION & COVERAGE
  2. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2016-2025 (USD MILLION)
  3. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ANALGESICS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY COUGH, COLD, AND FLU PRODUCTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DERMATOLOGY PRODUCTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GASTROINTESTINAL PRODUCTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  8. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY OPHTHALMIC PRODUCTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  9. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY SLEEPING AIDS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  10. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS), BY GEOGRAPHY, 2016-2025 (USD MILLION)
  11. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY WEIGHT-LOSS/DIETARY PRODUCTS, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  12. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  13. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY HOSPITAL PARMICIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  14. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY ONLINE STORES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  15. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2016-2025 (USD MILLION)
  16. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  17. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  18. AMERICAS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  19. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  20. ARGENTINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  21. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  22. BRAZIL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  23. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  24. CANADA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  25. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  26. MEXICO OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  27. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  28. UNITED STATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  29. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  30. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  31. ASIA-PACIFIC OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  32. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  33. AUSTRALIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  34. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  35. CHINA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  36. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  37. INDIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  38. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  39. INDONESIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  40. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  41. JAPAN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  42. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  43. MALAYSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  44. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  45. PHILIPPINES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  46. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  47. SOUTH KOREA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  48. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  49. THAILAND OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  50. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY COUNTRY, 2016-2025 (USD MILLION)
  51. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  52. EUROPE, MIDDLE EAST & AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  53. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  54. FRANCE OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  55. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  56. GERMANY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  57. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  58. ITALY OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  59. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  60. NETHERLANDS OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  61. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  62. QATAR OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  63. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  64. RUSSIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  65. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  66. SAUDI ARABIA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  67. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  68. SOUTH AFRICA OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  69. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  70. SPAIN OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  71. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  72. UNITED ARAB EMIRATES OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  73. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2016-2025 (USD MILLION)
  74. UNITED KINGDOM OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2016-2025 (USD MILLION)
  75. GLOBAL OVER THE COUNTER DRUGS MARKET: RANKING
  76. GLOBAL OVER THE COUNTER DRUGS MARKET: BUSINESS STRATEGY
  77. GLOBAL OVER THE COUNTER DRUGS MARKET: PRODUCT SATISFACTION
  78. GLOBAL OVER THE COUNTER DRUGS MARKET: EDITION DETAILS
  79. GLOBAL OVER THE COUNTER DRUGS MARKET: LICENSE DETAILS
  80. GLOBAL OVER THE COUNTER DRUGS MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH PROCESS
  2. GLOBAL OVER THE COUNTER DRUGS MARKET: RESEARCH FRAMEWORK
  3. GLOBAL OVER THE COUNTER DRUGS MARKET: FORECASTING METHODOLOGY
  4. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, 2016-2025 (USD MILLION)
  5. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY GEOGRAPHY, 2018 VS 2025 (USD MILLION)
  6. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2018 VS 2025 (USD MILLION)
  7. GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018 VS 2025 (USD MILLION)
  8. GLOBAL OVER THE COUNTER DRUGS MARKET: MARKET DYNAMICS
  9. GLOBAL OVER THE COUNTER DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY PRODUCT, 2025 (USD MILLION)
  11. GLOBAL OVER THE COUNTER DRUGS MARKET, BY ANALGESICS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  12. GLOBAL OVER THE COUNTER DRUGS MARKET, BY COUGH, COLD, AND FLU PRODUCTS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  13. GLOBAL OVER THE COUNTER DRUGS MARKET, BY DERMATOLOGY PRODUCTS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  14. GLOBAL OVER THE COUNTER DRUGS MARKET, BY GASTROINTESTINAL PRODUCTS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  15. GLOBAL OVER THE COUNTER DRUGS MARKET, BY OPHTHALMIC PRODUCTS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  16. GLOBAL OVER THE COUNTER DRUGS MARKET, BY SLEEPING AIDS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  17. GLOBAL OVER THE COUNTER DRUGS MARKET, BY VITAMINS, MINERAL, AND SUPPLEMENTS (VMS) SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  18. GLOBAL OVER THE COUNTER DRUGS MARKET, BY WEIGHT-LOSS/DIETARY PRODUCTS SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL OVER THE COUNTER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 (USD MILLION)
  20. GLOBAL OVER THE COUNTER DRUGS MARKET, BY HOSPITAL PARMICIES SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  21. GLOBAL OVER THE COUNTER DRUGS MARKET, BY ONLINE STORES SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  22. GLOBAL OVER THE COUNTER DRUGS MARKET, BY RETAIL PHARMACIES SIZE, BY GEOGRAPHY, 2018 (USD MILLION)
  23. GLOBAL OVER THE COUNTER DRUGS MARKET: FPNV POSITIONING MATRIX
  24. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL OVER THE COUNTER DRUGS MARKET, BY COMPANY
  25. COMPETITIVE NEWS FEED ANALYSIS IN GLOBAL OVER THE COUNTER DRUGS MARKET, BY YEAR
  1. Bayer AG
  2. Johnson & Johnson
  3. Novartis AG
  4. Pfizer Inc.
  5. Sanofi S.A.
  6. Alkem Laboratories Limited
  7. Boehringer Ingelheim GmbH
  8. Cipla, Inc.
  9. Glaxosmithkline PLC
  10. Glenmark Pharmaceuticals Limited
  11. Merck KGaA
  12. Sun Pharmaceutical Industries Ltd.
  13. Teva Pharmaceutical Industries Ltd.
Global Over The Counter Drugs Market
Report Code
MRR-7358D27
Publishing Date
June 2019
Number of Pages
150
Available Formats

SELECT LICENSE TYPE

ENTERPRISE USER LICENSE $9449
CORPORATE USER LICENSE $7449
SINGLE USER LICENSE $5449

Trusted by 2,000+ Companies Worldwide

Here's what some of our customers say about our work.
We appreciate all of our customers' testimonials.